Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis

Written by Customer Service on February 26, 2022. Posted in Public Companies.

Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis Dupixent 300 mg weekly is the only biologic medicine to show positive, clinically meaningful Phase 3 results in adults and adolescents with eosinophilic esophagitis Data continue to support well-established safety profile of Dupixent U.S. and global regulatory filings are planned in 2022 Paris and Tarrytown, N.Y., February 26, 2022. Positive detailed results from a second Phase 3 trial showed that Dupixent® (dupilumab) 300 mg weekly significantly improved the signs and symptoms of eosinophilic esophagitis (EoE) at 24 weeks compared to placebo in patients 12 years and older. Eosinophilic esophagitis is a chronic, progressive type 2 inflammatory disease that damages the esophagus and prevents...

Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria

Written by Customer Service on February 26, 2022. Posted in Public Companies.

Late-breaking phase 3 data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly reduced itch and hives in patients with chronic spontaneous urticaria In this Phase 3 trial, Dupixent added to standard-of-care antihistamines nearly doubled reduction in itch and urticaria activity scores compared to standard-of-care alone at 24 weeks in biologic-naïve patients uncontrolled on antihistamines Data reinforce the potential of targeting IL-4 and IL-13, key drivers of type 2 inflammation, in this complex, chronic disease Data support the well-established safety profile of Dupixent Paris and Tarrytown, N.Y., February 26, 2022. Detailed results from a Phase 3 trial showed that adding Dupixent® (dupilumab) to standard-of-care antihistamines significantly reduced itch and hives at 24 weeks in biologic-naïve patients with chronic...

Alpha Copper Closes $7,577,267 Private Placement

Written by Customer Service on February 26, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 25, 2022 (GLOBE NEWSWIRE) — Alpha Copper Corp. (the “Company”) (CSE: ALCU) is pleased to announce that it has closed its non-brokered private placement (the “Private Placement”) of 2,011,037 flow-through units (each, an “FT Unit“) of the Company at $0.65 per FT Unit and 12,540,186 non-flow-through units (each, an “NFT Unit“) of the Company at $0.50 per NFT Unit, for aggregate gross proceeds of $7,577,267.05. Each FT Unit is composed of one common share of the Company (each, a “Common Share”), issued on a flow-through basis pursuant the Income Tax Act (Canada) (the “ITA”), and one common share purchase warrant (each, a “Warrant“). Each Warrant will be exercisable at $1.00 per share for a period of two years from the date of issuance. Each NFT Unit is composed...

Tautachrome (OTC: TTCM) Targets Criminal Stock Trolls and Forums that Protect Them

Written by Customer Service on February 26, 2022. Posted in Public Companies.

ORO VALLEY, Ariz., Feb. 25, 2022 (GLOBE NEWSWIRE) — Tautachrome Inc. (OTC: TTCM) today describes the direction and focus of its integrity defense activity seeking to curb stock troll criminality aimed at the Company’s securities. The Company understands that internet platforms of all kinds exist that empower anybody to speak or shout-out comment of every kind. And we consider that good. But we also believe that the power to comment does not carry the right to criminally troll, that is to hide behind pseudonyms and make false and misleading statements aimed at damaging others. As we announced earlier this week, the Company has established an integrity defense activity aimed at curbing stock troll attacks against Company’s securities and has reactivated Michael Nugent, our former advancement official, to lead the activity. Mr. Nugent...

A.I.S. Resources Announces Warrants Extension

Written by Customer Service on February 26, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 25, 2022 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSX: AIS, OTCQB: AISSF) (the “Company” or “AIS”) announces that it intends, subject to TSX Venture Exchange approval, to extend the term of 12,622,222 warrants expiring on February 26, 2022. The share purchase warrants were issued pursuant to a private placement of 12,622,222 units accepted for filing by the TSXV on February 26, 2019. The warrants will be extended for a period of one year until February 26, 2023. The exercise price remains unchanged at $0.12. About A.I.S. Resources LimitedA.I.S. Resources Limited is a publicly traded investment issuer listed on the TSX Venture Exchange focused on precious and base metals exploration. AIS’ value add strategy is to acquire prospective exploration projects and enhance their value by better defining...

Euro Manganese Announces Results of Annual General and Special Meeting

Written by Customer Service on February 26, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 25, 2022 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the “Company” or “EMN“) is pleased to announce that shareholders have voted in favour of all matters of business brought before them at the Company’s Annual General & Special Meeting of shareholders (the “Meeting“) held on February 25, 2022. Detailed results of the voting from the Meeting are set out below. In respect of election of the Company’s directors, all five management nominees standing for re-election were elected as set out below based on a vote conducted by ballot: Nominee Total Votes Cast Votes For % For Votes Withheld (Abstained) % Withheld (Abstained) John Webster 132,618,497 96,614,242 72.85 36,004,255 27.15 Matthew P. James 132,618,497 114,465,603 86.31 18,152,894 13.69 David...

TAAT™ Enters into Agreement to Acquire Ohio-Based Distributor to Enhance its Position in the U.S. Tobacco Industry

Written by Customer Service on February 26, 2022. Posted in Mergers And Acquisitions.

Picture 1 The Company has entered into an agreement to acquire HLND, which will provide TAAT™ with its own wholesale presence in the Great Lakes region of the United States. HLND operates a long-established convenience distribution network in categories to include tobacco, snacks, candy, and various other convenience products. LAS VEGAS and VANCOUVER, British Columbia, Feb. 25, 2022 (GLOBE NEWSWIRE) — TAAT™ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that it has entered into an agreement dated Friday, February 25, 2022 to acquire HLND Holdings, Inc. (“HLND”), the parent entity of a convenience and tobacco wholesaler based in Ohio. HLND presently maintains a network of more than 5,000 convenience stores through its direct and indirect relationships with...

XR Immersive Tech Inc. Announces Update to $3,000,000 Facility With Westdale Construction Co. Limited

Written by Customer Service on February 26, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 25, 2022 (GLOBE NEWSWIRE) — XR Immersive Tech Inc. (formerly known as Fantasy 360 Technologies Inc.) (“Immersive Tech” or the “Company“) (CSE:VRAR) (FSE: 79W0) (OTCQB: FNTTF) is pleased to announce an update with respect to the loan facility from Westdale Construction Co. Limited (“Westdale“), as previously announced in a news release dated December 20, 2021. The Company announces that, pursuant to a finder’s fee agreement (the “Finder’s Agreement“) between the Company and Generation PMCA Corp. (“Generation“) dated October 14, 2021, the Company has paid, as consideration for Generation having introduced Westdale to the Company, a finder’s fee consisting of a cash payment in the amount of $150,000 to Generation and issued...

Stellantis Publishes 2021 Annual Report and Files Form 20-F and Provides Calendar of Proposed Dividend Distribution

Written by Customer Service on February 26, 2022. Posted in Dividend Reports And Estimates.

Stellantis Publishes 2021 Annual Report and Files Form 20-F andProvides Calendar of Proposed Dividend Distribution AMSTERDAM, February 25, 2022 – Stellantis N.V. announced today that it published its 2021 Annual Report and filed its 2021 Form 20-F with the United States Securities and Exchange Commission. Stellantis’ Annual Report and Form 20-F are available under the Investors section of the Stellantis corporate website at www.stellantis.com, where they can be viewed and downloaded.1 Shareholders may request a hard copy of these materials, free of charge, through the contact below. In addition, as announced on February 23, 2022, Stellantis’ Board of Directors intends to recommend to the Company’s shareholders a total distribution from the profits for the year to the holders of common shares of approximately €3.3 billion (approximately...

Day: February 26, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice